In VitroEfficacy of High-Dose Tobramycin against Burkholderia cepacia Complex and Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

A Burkholderia cenocepacia gene encoding a non-functional tyrosine phosphatase is required for the delayed maturation of the bacteria-containing vacuoles in macrophages

(2014) A. Andrade et al.   MICROBIOLOGY-SGM

Biofilm Compared to Conventional Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

(2013) Kitty Wu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients

(2013) Valerie Waters et al.   Journal of Cystic Fibrosis

Applying insights from biofilm biology to drug development — can a new approach be developed?

(2013) Thomas Bjarnsholt et al.   NATURE REVIEWS DRUG DISCOVERY

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

(2012) J. S. Brooke   CLINICAL MICROBIOLOGY REVIEWS

New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas

(2012) Valerie Waters   CURRENT PHARMACEUTICAL DESIGN

In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells

(2012) Q. Yu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids

(2012) Francis J. Gilchrist et al.   Journal of Cystic Fibrosis

In VitroSusceptibility of Burkholderia vietnamiensis to Aminoglycosides

(2011) Agatha N. Jassem et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Can Early Burkholderia cepacia Complex Infection in Cystic Fibrosis be Eradicated with Antibiotic Therapy?

(2011) Alex Horsley et al.   Frontiers in Cellular and Infection Microbiology

Stenotrophomonas maltophiliain Cystic Fibrosis

(2010) Valerie Waters et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

(2010) Michael W. Konstan et al.   Journal of Cystic Fibrosis

Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance

(2009) Silvia Buroni et al.   BMC MICROBIOLOGY

Successful treatment of cepacia syndrome

(2009) K. Grimwood et al.   Journal of Cystic Fibrosis

Survival After Lung Transplantation of Cystic Fibrosis Patients Infected with Burkholderia cepacia Complex

(2008) B. D. Alexander et al.   AMERICAN JOURNAL OF TRANSPLANTATION